ScreenerHero
MVIRMedivir AB (publ)
STO · SE · Healthcare · Biotechnology · medivir.com
1.900SEK+2.15%Mkt Cap: 112.30M $P/E: —

Medivir AB (publ), a pharmaceutical company, focuses on the development and commercialization of medical treatments in areas of high unmet medical need in Sweden, the Nordic region, the rest of Europe, and internationall…

Industry Peers

Biotechnology
Screen all
VX1
Vertex Pharmaceuticals Incorporated
$130.23BUSDP/E 32.1
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
argenx SE
$61.34BUSDP/E 39.8
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5

Key Statistics

Company
Market Cap112.30M $
Enterprise Value73.43M $
Revenue (TTM)861.44K $
Gross Profit-2.95M $
Net Income (TTM)-9.03M $
Revenue/Share0.0036 USD
Last Price1.900 SEK
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees7
CountrySE
SectorHealthcare
IndustryBiotechnology
ISINSE0020181014
Valuation
P/E (Trailing)—
P/E (Forward)-1.70
PEG0.74
EV/EBITDA-8.64
EV/Revenue85.24
P/S144.82
P/B5.89
EPS (TTM)-0.56
EPS (Forward)-1.23
52W Range
0.340061% of range2.885
52W High2.885 SEK
52W Low0.3400 SEK
Profitability
Gross Margin0.00%
Oper. Margin-872.73%
EBITDA Margin0.00%
Profit Margin-1109.80%
ROE-60.82%
ROA-47.87%
Growth
Revenue Growth83.30%
Earnings Growth—
Cash Flow & Leverage
Operating CF-7.02M $
CapEx (TTM)—
FCF Margin-661.38%
FCF Yield-5.07%
Net Debt-13.65M $
Net Debt/EBITDA1.61
Balance Sheet
Debt/Equity0.05
Current Ratio5.34
Quick Ratio5.34
Book Value/Sh0.3550 SEK
Cash/Share0.2770 SEK
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 SEK
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div DateMay 9, 1996
Pay Date—
Analyst Consensus
Rating—
Target (Mean)5.468 SEK
Upside (mean)+187.8%
Target Range4.000 SEK – 6.937 SEK
SEK4.000+187.8% to meanSEK6.937
# Analysts2
Ownership
Shares Out.617.94M
Float297.39M
Insiders36.46%
Institutions15.53%
Technical
SMA 501.737 (+9.4%)
SMA 2001.395 (+36.2%)
Beta0.10
S&P 52W Chg18.16%
Avg Vol (30d)1.39M
Avg Vol (10d)1.10M
Technical Indicators
RSI (14)57.8
MACD-0.0050
MACD Signal-0.0013
MACD Hist.-0.0037
BB Upper1.903 SEK
BB Middle1.774 SEK
BB Lower1.645 SEK
BB Width14.53%
ATR (14)0.0937 SEK
Vol Ratio (20d)3.23x